Connection

Seungtaek Kim to Middle East Respiratory Syndrome Coronavirus

Back to Details
This is a "connection" page, showing publications Seungtaek Kim has written about Middle East Respiratory Syndrome Coronavirus.
Seungtaek Kim
Connection Strength
0.101
Middle East Respiratory Syndrome Coronavirus
  1. Design, synthesis and biological evaluation of 2-aminoquinazolin-4(3H)-one derivatives as potential SARS-CoV-2 and MERS-CoV treatments. Bioorg Med Chem Lett. 2021 05 01; 39:127885.
    View in: PubMed
    Score: 0.047
  2. Generation of a Nebulizable CDR-Modified MERS-CoV Neutralizing Human Antibody. Int J Mol Sci. 2019 Oct 12; 20(20).
    View in: PubMed
    Score: 0.043
  3. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections. Phytomedicine. 2021 Jun; 86:153440.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.